Onconetix Inc (ONCO)

$0.72 -0.03 (-4.04%)
Market Cap 864,000.00
Revenue (ttm) 820,000.00
Net Income (ttm) -14.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,710.98%
Debt to Equity Ratio 0.00
Volume 213,274
Avg Vol 611,958
Day's Range N/A - N/A
Shares Out 1.14M
Stochastic %K 14%
Beta 2.69
Analysts Strong Buy
Price Target N/A

Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the Panc...

Industry: Biotechnology
Sector: Healthcare
Phone: 513 620 4101
Address:
201 East Fifth Street, Suite 1900, Cincinnati, United States
URANIUM77
URANIUM77 Aug. 19 at 3:28 PM
$ONCO BOOM is coming https://finance.yahoo.com/technology/ai/articles/humanoid-maker-unitree-surges-more-071525970.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAD3U639U-XrfUN0Zh2UkUO3V0i1RXLxRJvip7T6FexjY5sllf6EloWuJ3O0vappdA6QLIU2Za-USbENWf4Pf1opWcVkkI6kcePbbAXlFVKd8jxbgJH-_bNhcyu5Xdh0a295B3goWshqX5txFbrsc2d9LOSpm6jRbRjDMdiSKjfLa
0 · Reply
URANIUM77
URANIUM77 Aug. 19 at 3:01 PM
$ONCO Loading zone now
0 · Reply
Mile111
Mile111 Aug. 19 at 4:22 AM
$ONCO Monster squezze comming!!!
1 · Reply
Mile111
Mile111 Aug. 18 at 5:41 PM
$ONCO 10 Dollar 🔥
0 · Reply
ShangVXO
ShangVXO Aug. 18 at 1:23 PM
Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $LGHL $ONCO searching for entry
0 · Reply
Gigi96
Gigi96 Aug. 18 at 1:10 PM
$ONCO earnings today???
0 · Reply
rubiconjay
rubiconjay Aug. 18 at 1:12 AM
$ONCO ⏰
0 · Reply
URANIUM77
URANIUM77 Aug. 14 at 7:07 PM
$ONCO Amazing loading zone now
0 · Reply
birdseyetrader
birdseyetrader Aug. 14 at 5:37 PM
$IPW on the verge of breakout could see $4 here like $ONCO did
0 · Reply
snider22
snider22 Aug. 14 at 5:18 PM
$IPW 550K float HAS A CLEAR GAP TO 39$ Chinese they love to stretch it green to the upside $ONCO $WETO ALL candidates 🔥🐦‍🔥
0 · Reply
Latest News on ONCO
Onconetix registers to sell 100M shares of common stock for holders

2026-08-17T09:02:06.000Z - 2 days ago

Onconetix registers to sell 100M shares of common stock for holders

Onconetix Quarterly report: Q2 2026

Aug 13, 2026, 7:00 AM EDT - 6 days ago

Onconetix Quarterly report: Q2 2026

Onconetix Registration statement: Registration filing

Aug 12, 2026, 8:00 AM EDT - 7 days ago

Onconetix Registration statement: Registration filing

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Aug 6, 2026, 8:30 AM EDT - 13 days ago

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Aug 5, 2026, 8:30 AM EDT - 14 days ago

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

Jul 7, 2026, 9:00 AM EDT - 6 weeks ago

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

Onconetix Highlights Realbotix's Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District

Jun 24, 2026, 8:30 AM EDT - 2 months ago

Onconetix Highlights Realbotix's Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District

Onco-Innovations Announces Non-Brokered LIFE Offering

Jun 19, 2026, 7:00 PM EDT - 2 months ago

Onco-Innovations Announces Non-Brokered LIFE Offering

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

Jun 19, 2026, 6:00 PM EDT - 2 months ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

Jun 16, 2026, 6:00 PM EDT - 2 months ago

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

Onconetix Registration statement: Registration filing

Jun 9, 2026, 8:00 AM EDT - 2 months ago

Onconetix Registration statement: Registration filing

Onconetix files to sell 100M shares of common stock for holders

2026-06-09T10:06:30.000Z - 2 months ago

Onconetix files to sell 100M shares of common stock for holders

Onconetix Inc trading halted, news pending

2026-05-20T23:50:10.000Z - 3 months ago

Onconetix Inc trading halted, news pending

Onconetix announces 1-for-10 reverse stock split

2026-05-19T12:39:58.000Z - 3 months ago

Onconetix announces 1-for-10 reverse stock split

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

May 19, 2026, 8:00 AM EDT - 3 months ago

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

Realbotix expects transaction with Onconetix to close by October

2026-05-19T11:47:20.000Z - 3 months ago

Realbotix expects transaction with Onconetix to close by October

Realbotix Provides Update on Nasdaq Listing

May 19, 2026, 7:30 AM EDT - 3 months ago

Realbotix Provides Update on Nasdaq Listing

Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

May 13, 2026, 9:25 AM EDT - 3 months ago

Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

Onconetix Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 3 months ago

Onconetix Quarterly report: Q1 2026

Onconetix Earnings release: Q1 2026

May 13, 2026, 7:00 AM EDT - 3 months ago

Onconetix Earnings release: Q1 2026

Onconetix Registration statement: Registration filing

May 7, 2026, 8:00 AM EDT - 3 months ago

Onconetix Registration statement: Registration filing

Onconetix files to sell 25M shares of common stock for holders

2026-04-28T20:18:54.000Z - 4 months ago

Onconetix files to sell 25M shares of common stock for holders

Onconetix Registration statement: Registration filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Onconetix Registration statement: Registration filing

Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson

Apr 9, 2026, 8:30 AM EDT - 4 months ago

Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Apr 2, 2026, 8:30 AM EDT - 4 months ago

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Onconetix CEO Karina Fedasz to step down, David White to succeed

2026-03-31T13:13:26.000Z - 5 months ago

Onconetix CEO Karina Fedasz to step down, David White to succeed

ARTW

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Mar 31, 2026, 8:30 AM EDT - 5 months ago

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Onconetix Proxy statement: Proxy filing

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Onconetix Proxy statement: Proxy filing

Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration

Mar 25, 2026, 12:47 PM EDT - 5 months ago

Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration

Onconetix Inc trading halted, news pending

2026-03-24T23:50:18.000Z - 5 months ago

Onconetix Inc trading halted, news pending

Onconetix announces 1-for-5 reverse stock split

2026-03-23T13:12:26.000Z - 5 months ago

Onconetix announces 1-for-5 reverse stock split

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Mar 23, 2026, 8:30 AM EDT - 5 months ago

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Onconetix Proxy statement: Proxy Filing

Mar 18, 2026, 8:00 AM EDT - 5 months ago

Onconetix Proxy statement: Proxy Filing

Onconetix Annual report: Q4 2025

Mar 13, 2026, 8:00 AM EDT - 5 months ago

Onconetix Annual report: Q4 2025

Onconetix to acquire Realbotix LLC in all-stock transaction

2026-02-12T13:27:43.000Z - 6 months ago

Onconetix to acquire Realbotix LLC in all-stock transaction

Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company

Feb 12, 2026, 8:00 AM EST - 6 months ago

Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company

Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Feb 12, 2026, 8:00 AM EST - 6 months ago

Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Onconetix Proxy statement: Proxy Filing

Jan 2, 2026, 7:00 AM EST - 8 months ago

Onconetix Proxy statement: Proxy Filing

Onconetix Registration statement: Registration Filing

Dec 22, 2025, 7:00 AM EST - 8 months ago

Onconetix Registration statement: Registration Filing

Onconetix Proxy statement: Proxy Filing

Dec 22, 2025, 7:00 AM EST - 8 months ago

Onconetix Proxy statement: Proxy Filing

Onconetix Proxy statement: Proxy Filing

Nov 10, 2025, 7:00 AM EST - 10 months ago

Onconetix Proxy statement: Proxy Filing

Onconetix files to sell 22.07M shares of common stock for holders

2025-11-04T21:45:43.000Z - 10 months ago

Onconetix files to sell 22.07M shares of common stock for holders

Onconetix Registration statement: Registration Filing

Nov 4, 2025, 7:00 AM EST - 10 months ago

Onconetix Registration statement: Registration Filing

Onconetix Proxy statement: Proxy Filing

Oct 29, 2025, 8:00 AM EDT - 10 months ago

Onconetix Proxy statement: Proxy Filing

Onconetix Registration statement: Registration Filing

Oct 16, 2025, 8:00 AM EDT - 10 months ago

Onconetix Registration statement: Registration Filing

Onconetix files to sell 5.1M shares of common stock for holders

2025-10-16T10:10:38.000Z - 10 months ago

Onconetix files to sell 5.1M shares of common stock for holders

Onconetix announces financing through private placement, debt settlement

2025-09-26T12:40:45.000Z - 11 months ago

Onconetix announces financing through private placement, debt settlement

VERU

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Sep 26, 2025, 8:30 AM EDT - 11 months ago

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Onconetix, Ocuvex announce mutual termination of merger agreement

2025-09-26T12:20:26.000Z - 11 months ago

Onconetix, Ocuvex announce mutual termination of merger agreement

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Sep 26, 2025, 8:15 AM EDT - 11 months ago

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Onconetix’s Proteomedix licenses manufacturing IP to Immunovia

2025-09-22T12:10:57.000Z - 11 months ago

Onconetix’s Proteomedix licenses manufacturing IP to Immunovia

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

Sep 22, 2025, 8:00 AM EDT - 11 months ago

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

Onconetix, Ocuvex execute definitive merger agreement

2025-07-16T12:21:02.000Z - 1 year ago

Onconetix, Ocuvex execute definitive merger agreement

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Jul 16, 2025, 8:17 AM EDT - 1 year ago

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Onconetix receives positive decision by Nasdaq Hearings Panel

2025-06-16T12:25:20.000Z - 1 year ago

Onconetix receives positive decision by Nasdaq Hearings Panel

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Jun 16, 2025, 8:22 AM EDT - 1 year ago

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Onconetix Inc trading halted, news pending

2025-06-12T23:50:23.000Z - 1 year ago

Onconetix Inc trading halted, news pending

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Jun 11, 2025, 11:30 AM EDT - 1 year ago

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

May 22, 2025, 4:50 PM EDT - 1 year ago

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

Onco-Innovations Uplists to Cboe Canada

May 22, 2025, 10:00 AM EDT - 1 year ago

Onco-Innovations Uplists to Cboe Canada

Onconetix Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Onconetix Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Onconetix Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Onconetix Proxy statement: Proxy Filing

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Mar 24, 2025, 8:45 AM EDT - 1 year ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Onconetix Registration statement: Registration Filing

Feb 7, 2025, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Onconetix Registration statement: Registration Filing

Jan 27, 2025, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Dec 12, 2024, 5:00 PM EST - 1 year ago

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Onconetix Registration statement: Registration Filing

Dec 11, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Onconetix Registration statement: Registration Filing

Dec 10, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Onconetix Registration statement: Registration Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Onconetix Registration statement: Registration Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Onconetix Registration statement: Registration Filing

Onconetix Registration statement: Registration Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Onconetix Registration statement: Registration Filing

Onconetix Registration statement: Registration Filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Onconetix Registration statement: Registration Filing

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

Oct 8, 2024, 5:00 AM EDT - 2 years ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

OCS VRNA GRDX

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 4:45 PM EDT - 2 years ago

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 9:05 AM EDT - 2 years ago

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Sep 20, 2024, 11:45 AM EDT - 2 years ago

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Onconetix Proxy statement: Proxy Filing

Sep 3, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Onconetix Proxy statement: Proxy Filing

Aug 1, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Onconetix Proxy statement: Proxy Filing

Jul 22, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Jul 15, 2024, 6:00 AM EDT - 2 years ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Jul 11, 2024, 8:17 AM EDT - 2 years ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Onconetix Registration statement: Registration Filing

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Onconetix Proxy statement: Proxy Filing

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Onconetix Registration statement: Registration Filing

Jun 5, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Onconetix Proxy statement: Proxy Filing

Jun 5, 2024, 8:00 AM EDT - 2 years ago

Onconetix Proxy statement: Proxy Filing

Onconetix Registration statement: Registration Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Onconetix Registration statement: Registration Filing

Onconetix Registration statement: Registration Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

Onconetix Registration statement: Registration Filing

Onconetix Proxy statement: Proxy Filing

Feb 14, 2024, 7:00 AM EST - 2 years ago

Onconetix Proxy statement: Proxy Filing

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Feb 13, 2024, 6:00 AM EST - 2 years ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Onconetix Slides: Corporate presentation

Jan 21, 2024, 7:00 AM EST - 2 years ago

Onconetix Slides: Corporate presentation

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Dec 19, 2023, 7:00 AM EST - 2 years ago

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Dec 18, 2023, 7:00 AM EST - 2 years ago

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Nov 2, 2023, 7:00 AM EDT - 3 years ago

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Nov 1, 2023, 7:00 AM EDT - 3 years ago

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Blue Water Biotech Issues Letter to Shareholders

Oct 30, 2023, 7:00 AM EDT - 3 years ago

Blue Water Biotech Issues Letter to Shareholders

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Oct 10, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Aug 28, 2023, 4:30 PM EDT - 3 years ago

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 3, 2023, 1:02 PM EDT - 3 years ago

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 1, 2023, 8:00 AM EDT - 3 years ago

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Jul 31, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Jul 25, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Jul 17, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Jul 11, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Jul 6, 2023, 5:05 PM EDT - 3 years ago

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

URANIUM77
URANIUM77 Aug. 19 at 3:28 PM
$ONCO BOOM is coming https://finance.yahoo.com/technology/ai/articles/humanoid-maker-unitree-surges-more-071525970.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAD3U639U-XrfUN0Zh2UkUO3V0i1RXLxRJvip7T6FexjY5sllf6EloWuJ3O0vappdA6QLIU2Za-USbENWf4Pf1opWcVkkI6kcePbbAXlFVKd8jxbgJH-_bNhcyu5Xdh0a295B3goWshqX5txFbrsc2d9LOSpm6jRbRjDMdiSKjfLa
0 · Reply
URANIUM77
URANIUM77 Aug. 19 at 3:01 PM
$ONCO Loading zone now
0 · Reply
Mile111
Mile111 Aug. 19 at 4:22 AM
$ONCO Monster squezze comming!!!
1 · Reply
Mile111
Mile111 Aug. 18 at 5:41 PM
$ONCO 10 Dollar 🔥
0 · Reply
ShangVXO
ShangVXO Aug. 18 at 1:23 PM
Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $LGHL $ONCO searching for entry
0 · Reply
Gigi96
Gigi96 Aug. 18 at 1:10 PM
$ONCO earnings today???
0 · Reply
rubiconjay
rubiconjay Aug. 18 at 1:12 AM
$ONCO ⏰
0 · Reply
URANIUM77
URANIUM77 Aug. 14 at 7:07 PM
$ONCO Amazing loading zone now
0 · Reply
birdseyetrader
birdseyetrader Aug. 14 at 5:37 PM
$IPW on the verge of breakout could see $4 here like $ONCO did
0 · Reply
snider22
snider22 Aug. 14 at 5:18 PM
$IPW 550K float HAS A CLEAR GAP TO 39$ Chinese they love to stretch it green to the upside $ONCO $WETO ALL candidates 🔥🐦‍🔥
0 · Reply
birdseyetrader
birdseyetrader Aug. 14 at 5:16 PM
$IPW Volume alert watch the breakout next $ONCO $MF ??
0 · Reply
RobbysInvestmentLLC
RobbysInvestmentLLC Aug. 14 at 5:12 PM
$IPW next leg $4 called $ONCO $GIPR $CAPR don’t miss this one 🚀🚀🚀🚀🚀
1 · Reply
birdseyetrader
birdseyetrader Aug. 14 at 5:10 PM
$IPW see the breakout formation another $CAPR $ONCO setup
0 · Reply
drweinerdog1
drweinerdog1 Aug. 14 at 4:53 PM
$ONCO at least that can’t dilute more than 700k without a vote of the shareholders
0 · Reply
Siara1620
Siara1620 Aug. 14 at 4:36 PM
$ONCO This trash is sinking. And the RR is going up.
0 · Reply
Adamwys
Adamwys Aug. 14 at 2:54 PM
$ONCO
1 · Reply
happyDaddy8
happyDaddy8 Aug. 14 at 2:19 PM
$ONCO are they diluting again? also do they need to RS before merger?
0 · Reply
drweinerdog1
drweinerdog1 Aug. 14 at 11:41 AM
$ONCO let’s pray for a dilution exit pump
0 · Reply
The_Titan_Traders
The_Titan_Traders Aug. 14 at 9:13 AM
Watching $WOK off $WETO / $ONCO
0 · Reply
URANIUM77
URANIUM77 Aug. 13 at 2:14 PM
$ONCO There is no more dilution Nearly $30 million in cash and only 3.69M shares That's 10x today's share price Upload now. https://dilutiontracker.com/app/search/ONCO
2 · Reply
Adamwys
Adamwys Aug. 13 at 9:46 AM
$ONCO POS won’t stop diluting
0 · Reply
adaghriri
adaghriri Aug. 13 at 2:25 AM
$ONCO The day of money 💰 day 💰
0 · Reply